Stockscreener 앱 받기
5.355
1.83%
-0.095
시간 외 거래:
5.35
-0.005
-0.09%
전일 마감가:
$5.45
열려 있는:
$5.46
하루 거래량:
479.14K
Relative Volume:
3.46
시가총액:
$191.98M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-4.63%
1개월 성능:
+11.00%
6개월 성능:
+55.98%
1년 성능:
-73.95%
1일 변동 폭
$5.245
$5.46
1주일 범위
$5.245
$5.80
52주 변동 폭
$2.88
$26.62
Bioage Labs Inc Stock (BIOA) Company Profile
명칭
Bioage Labs Inc
전화
510-806-1445
주소
5885 HOLLIS STREET, EMERYVILLE
BIOA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIOA
Bioage Labs Inc
|
5.355 | 195.38M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
141.09 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
439.99 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-28 | 개시 | William Blair | Mkt Perform |
| 2024-12-10 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2024-12-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-09 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-10-21 | 개시 | Citigroup | Buy |
| 2024-10-21 | 개시 | Jefferies | Buy |
| 2024-10-21 | 개시 | Morgan Stanley | Overweight |
모두보기
Bioage Labs Inc 주식(BIOA)의 최신 뉴스
Short interest data insights for BioAge Labs Inc.2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com
BioAge Labs (NASDAQ:BIOA) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
Can BioAge Labs Inc. stock sustain revenue growthPortfolio Return Summary & Real-Time Volume Analysis Alerts - newser.com
Can trapped investors hope for a rebound in BioAge Labs Inc.2025 Analyst Calls & Growth Focused Entry Reports - newser.com
What drives BioAge Labs Inc stock priceEarnings Surprise Analysis & Minimal Investment Trading - earlytimes.in
Developing predictive dashboards with BioAge Labs Inc. data2025 Key Lessons & Weekly Top Gainers Trade List - newser.com
Can momentum traders help lift BioAge Labs Inc.M&A Rumor & Weekly High Conviction Ideas - newser.com
Using Ichimoku Cloud for BioAge Labs Inc. technicals2025 Top Gainers & Low Risk Entry Point Guides - newser.com
Will BioAge Labs Inc. stock outperform tech sector in 20252025 Geopolitical Influence & Capital Protection Trading Alerts - newser.com
How strong is BioAge Labs Inc. (Y7G) stock earnings growth2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com
Analyzing net buyer seller activity in BioAge Labs Inc.Market Rally & Low Drawdown Investment Ideas - newser.com
BIOAGE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
How high can BioAge Labs Inc. stock go2025 Buyback Activity & Precise Buy Zone Tips - newser.com
BioAge Labs files for mixed shelf offering of up to $250 millionSEC filing - MarketScreener
BioAge Labs Files $250 Million Mixed Shelf - MarketScreener
Is BioAge Labs Inc a good long term investmentStock Valuation Metrics & Your Free Entry to Smart Investing Starts Here - earlytimes.in
What analysts say about BioAge Labs Inc Y7G stockMarket Capitalization Trends & Reap the Rewards of Patience + Planning - earlytimes.in
BioAge Labs Inc Y7G Stock Analysis and ForecastFibonacci Extensions & Build Winning Portfolio - earlytimes.in
BioAge Labs, Inc. (NASDAQ:BIOA) institutional owners may be pleased with recent gains after 74% loss over the past year - simplywall.st
Bioage Labs Inc (BIOA) 재무 분석
Bioage Labs Inc (BIOA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.54%
1.16%
자본화:
|
볼륨(24시간):